Federal Register / Vol. 63, No. 97 /Wednesday, May 20, 1998 / Notices 27727

E. Safety Determination

1. U.S. population. Using the

conservative exposure assumptions and

the proposed RfD described above, the

aggregate exposure to pymetrozine will

utilize 3.78% of the RfD for the U.S.

population. EPA generally has no

concern for exposures below 100% of

the RfD because the RfD represents the

level at or below which daily aggregate

exposure over a lifetime will not pose

appreciable risks to human health.

Therefore, Novartis concludes that there

is a reasonable certainty that no harm

will result from aggregate exposure to

pymetrozine residues.

2. Infants and children. In assessing

the potential for additional sensitivity of

infants and children to residues of

pymetrozine, data from developmental

toxicity studies in the rat and rabbit and

a two-generation reproduction study in

the rat have been considered.

In a teratology study in rats,

developmental toxicity anomalies and

variations associated was observed only

at maternally toxic doses. Similarly, in

a rabbit teratology study, was observed

only at maternally toxic doses. The

NOELs in the rat and rabbit teratology

studies were 30 and 10 mg/kg/day,

respectively. In the two-generation

reproduction study, there were no

effects on reproductive parameters.

Offspring body weights were slightly

reduced and eye opening was slightly

delayed at dose levels producing

parental toxicity. The NOEL for parental

and offspring toxicity was 20 ppm

(approximately 1–4 mg/kg/day).

FFDCA section 408 provides that EPA

may apply an additional safety factor for

infants and children in the case of

threshold effects to account for pre- and

post-natal toxicity and the completeness

of the database. Based on the current

toxicological requirements, the database

relative to pre- and post-natal effects for

children is complete. Further, for

pymetrozine, the NOEL of 0.57 from the

chronic feeding study in dogs, which

was used to calculate the RfD (0.0057

mg/kg/day), is already lower than the

developmental NOELs (30 and 10 mg/

kg/day) from the teratogenicity studies

in rats and rabbits by a factor of more

than tenfold. In the pymetrozine rat

reproduction study, the mild nature of

the effects observed (decreased body

weight) at the systemic LOEL (10–40

mg/kg/day) and the fact that the effects

were observed at a dose that is more

than 10 times greater than the NOEL in

the chronic dog study (0.57 mg/kg/day)

suggest that there is no additional

sensitivity for infants and children.

Therefore, it is concluded that an

additional uncertainty factor is not

warranted to protect the health of

infants and children and that an RfD of

0.0057 mg/kg/day based on the chronic

dog study is appropriate for assessing

aggregate risk to infants and children

from pymetrozine.

Using the exposure assumptions

described above, the percent of the RfD

that will be utilized by aggregate

exposure to residues of pymetrozine is

0.43% for nursing infants less than 1

year old, 1.49% for non-nursing infants,

3.44% for children 1–6 years old and

2.72% for children 7–12 years old.

Therefore, based on the completeness

and reliability of the toxicity database,

Novartis concludes that there is a

reasonable certainty that no harm will

result to infants and children from

aggregate exposure to pymetrozine

residues.

F. International Tolerances

There are no Codex maximum levels

established for residues of pymetrozine.

[FR Doc. 98–13447 Filed 5–19–98; 8:45 am]

BILLING CODE 6560–50–F

ENVIRONMENTAL PROTECTION

AGENCY

[PF–804; FRL–5788–8]

Westvaco Corporation; Pesticide

Tolerance Petition Filing

AGENCY: Environmental Protection

Agency (EPA).

ACTION: Notice.

SUMMARY: This notice announces the

initial filing of a pesticide petition

proposing the establishment of

regulations for residues of a certain

pesticide chemical in or on various food

commodities.

DATES: Comments, identified by the

docket control number PF–804, must be

received on or before June 19, 1998.

ADDRESSES: By mail submit written

comments to: Information and Records

Integrity Branch, Public Information and

Services Divison (7502C), Office of

Pesticides Programs, Environmental

Protection Agency, 401 M St., SW.,

Washington, DC 20460. In person bring

comments to: Rm. 119, CM #2, 1921

Jefferson Davis Highway, Arlington, VA.

Comments and data may also be

submitted electronically by following

the instructions under

‘‘SUPPLEMENTARY INFORMATION.’’

No confidential business information

should be submitted through e-mail.

Information submitted as a comment

concerning this document may be

claimed confidential by marking any

part or all of that information as

‘‘Confidential Business Information’’

(CBI). CBI should not be submitted

through e-mail. Information marked as

CBI will not be disclosed except in

accordance with procedures set forth in

40 CFR part 2. A copy of the comment

that does not contain CBI must be

submitted for inclusion in the public

record. Information not marked

confidential may be disclosed publicly

by EPA without prior notice. All written

comments will be available for public

inspection in Rm. 119 at the address

given above, from 8:30 a.m. to 4 p.m.,

Monday through Friday, excluding legal

holidays.

FOR FURTHER INFORMATION CONTACT:

Bipin C. Gandhi, Registration Support

Branch, Registration Division (7505W),

Office of Pesticide Programs,

Environmental Protection Agency, 401

M St., SW, Washington, DC 20460.

Office location, telephone number, and

e-mail address: Rm. 4-W53, Crystal

Station ι1, 2800 Jefferson Davis

Highway, Arlington, VA 22202, (703)

308–8380; e-mail:

gandhi.bipin@epamail.epa.gov.

SUPPLEMENTARY INFORMATION: EPA has

received a pesticide petition as follows

proposing the establishment and/or

amendment of regulations for residues

of certain pesticide chemical in or on

various food commodities under section

408 of the Federal Food, Drug, and

Comestic Act (FFDCA), 21 U.S.C. 346a.

EPA has determined that this petition

contains data or information regarding

the elements set forth in section

408(d)(2); however, EPA has not fully

evaluated the sufficiency of the

submitted data at this time or whether

the data supports granting of the

petition. Additional data may be needed

before EPA rules on the petition.

The official record for this notice of

filing, as well as the public version, has

been established for this notice of filing

under docket control number [PF–804]

(including comments and data

submitted electronically as described

below). A public version of this record,

including printed, paper versions of

electronic comments, which does not

include any information claimed as CBI,

is available for inspection from 8:30

a.m. to 4 p.m., Monday through Friday,

excluding legal holidays. The official

record is located at the address in

‘‘ADDRESSES’’ at the beginning of this

document.

Electronic comments can be sent

directly to EPA at:

opp-docket@epamail.epa.gov

Electronic comments must be

submitted as an ASCII file avoiding the

use of special characters and any form

of encryption. Comment and data will
27728 Federal Register / Vol. 63, No. 97 /Wednesday, May 20, 1998 / Notices

also be accepted on disks in

Wordperfect 5.1/6.1 file format or ASCII

file format. All comments and data in

electronic form must be identified by

the docket control number (PF–804) and

appropriate petition number. Electronic

comments on this notice may be filed

online at many Federal Depository

Libraries.

List of Subjects

Environmental protection,

Agricultural commodities, Food

additives, Feed additives, Pesticides and

pests, Reporting and recordkeeping

requirements.

Dated: May 4, 1998.

Peter Caulkins,

Acting Director, Registration Division, Office

of Pesticide Programs.

Summaries of Petitions

Petitioner summaries of the pesticide

petitions are printed below as required

by section 408(d)(3) of the FFDCA. The

summaries of the petitions were

prepared by the petitioners and

represent the views of the petitioners.

EPA is publishing the petition

summaries verbatim without editing

them in any way. The petition summary

announces the availability of a

description of the analytical methods

available to EPA for the detection and

measurement of the pesticide chemical

residues or an explanation of why no

such method is needed.

1. Westvaco Corporation

PP 6E4749

EPA has received a pesticide petition

(PP 6E4749) from Westvaco

Corporation, Chemical Division, 3950

Faber Place Drive, North Charleston, SC

29405, proposing pursuant to section

408(d) of the Federal Food, Drug and

Cosmetic Act, 21 U.S.C. 346a(d), to

amend 40 CFR part 180 to establish an

exemption from the requirement of a

tolerance for residues of acrylic acid,

styrene, alpha-methyl styrene

copolymer ammonium salt (CAS Reg.

No. 89678-90-0) when used as an inert

ingredient (encapsulating agent,

dispensers, resins, fibers and beads) in

pesticide formulations applied to

growing crops or raw agricultural

commodities after harvest, under 40

CFR 180.1001(c) and applied to animals

under 40 CFR 180.1001(e). EPA has

determined that the petition contains

data or information regarding the

elements set forth in section 408(d)(2) of

the FFDCA; however, EPA has not fully

evaluated the sufficiency of the

submitted data at this time or whether

the data supports granting of the

petition. Additional data may be needed

before EPA rules on the petition.

A. Toxicity Data

As part of the EPA policy statement

on inert ingredients published in the

Federal Register of April 22, 1987 (52

FR 13305) (FRL–3190-1), the Agency set

forth a list of studies which would

generally be used to evaluate the risks

posed by the presence of an inert

ingredient in a pesticide formulation.

However, where it can be determined

without the data that the inert

ingredient will present minimal or no

risk, the Agency generally does not

require some or all of the listed studies

to rule on the proposed tolerance or

exemption from the requirement of a

tolerance for an inert ingredient.

Westvaco believes that the data and

information described below is adequate

to ascertain the toxicology and

characterize the risk associated with the

use of acrylic acid, styrene, alphamethyl styrene copolymer ammonium

salt (CAS Reg. No. 89678-90-0) as an

inert ingredient in pesticide

formulations applied to growing crops

and raw agricultural commodities after

harvest.

In the case of certain chemical

substances that are defined as

‘‘polymers’’ the EPA has established a

set of criteria which identify categories

of polymers that present low risk. These

criteria (described in 40 CFR 723.250)

identify polymers that are relatively

unreactive and stable compared to other

chemical substances as well as polymers

that typically are not readily absorbed.

These properties generally limit a

polymer’s ability to cause adverse

effects. In addition, these criteria

exclude polymers about which little is

known. The EPA believes that polymers

meeting the criteria noted below will

present minimal or no risk.

Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt (CAS

Reg. No. 89678-90-0) conforms to the

definition of polymer given in 40 CFR

723.250(b) and meets the following

criteria that are used to identify low risk

polymers.

1. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt is

not a cationic polymer, nor is it

reasonably anticipated to become a

cationic polymer in a natural aquatic

environment.

2. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt

contains as an integral part of its

composition the atomic elements carbon

and hydrogen.

3. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt does

not contain as an integral part of its

composition, except as impurities, any

elements other than those listed in 40

CFR 723.250(d)(2)(ii).

4. Acrylic acid, styrene, alpha-methyl

styrene ammonium salt copolymer is

not designed, nor is it reasonably

anticipated to substantially degrade,

decompose, or depolymerize.

5. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt is

not manufactured or imported from

monomers and/or other reactants that

are not already included on the Toxic

Substance Control Act (TSCA) Chemical

Substance Inventory or manufactured

under an applicable TSCA section 5

exemption.

6. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt is

not a water absorbing polymer.

7. Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt does

not contain any group as reactive

functional groups.

8. The minimum number-average

molecular weight of the acrylic acid,

styrene, alpha-methyl styrene

copolymer is listed as 1,200 daltons.

Substances with molecular weights

greater than 400 generally are not

absorbed through the intact skin, and

substances with molecular weights

greater than 1,000 generally are not

absorbed through the intact

gastrointestinal (GI) tract. Chemicals not

absorbed through the skin or GI tract

generally are incapable of eliciting a

toxic response.

9. The Acrylic acid, styrene, alphamethyl styrene copolymer has a

number-average molecular weight of

1,200 and contains less than 10%

oligomeric material below molecular

weight 500 and less than 25%

oligomeric material below 1,000

molecular weight.

In addition, acrylic acid, styrene,

alpha-methyl styrene copolymer is

approved by the Food and Drug

Administration (FDA) under 21 CFR for

contact with food as a component in

adhesives (21 CFR 175.105), coatings

(21 CFR 175.300), and paper and

paperboard (21 CFR 176.170). The

ammonium hydroxide utilized to form

the ammonium salt is listed in 21 CFR

184.1139 under the section, ‘‘Direct food

substances affirmed as generally

recognized as safe’’.

B. Aggregate Exposure

Acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt

formulations have been in commerce

since the mid 1960’s. The copolymer is

ubiquitous in our every day

environment and as it is commonly

used in flexographic printing inks and

coatings, such as on newspapers,
Federal Register / Vol. 63, No. 97 /Wednesday, May 20, 1998 / Notices 27729

corrugated boxes (e.g. pizza boxes) and

disposable drinking cups.

Although exposure to acrylic acid,

styrene, alpha-methyl styrene

copolymer ammonium salt may occur

through dietary (e.g., food wrapping

containing copolymer) and nonoccupational (e.g., printed articles)

sources, the chemical characteristics of

acrylic acid, styrene, alpha-methyl

styrenecopolymer ammonium salt lead

to the conclusion that there is a

reasonable certainty of no harm from

aggregate exposure to the polymer.

Given the existing widespread and

historic use of acrylic acid, styrene,

alpha-methyl styrene copolymer

ammonium salt, any additional

exposure resulting from the approval of

the copolymer as an inert ingredient in

pesticide formulations for use on

growing crops or to raw agricultural

commodities after harvest is not

warranted.

C. Cumulative Effects

At this time there is no information to

indicate that any toxic effects produced

by acrylic acid, styrene, alpha-methyl

styrene copolymer ammonium salt

would be cumulative with those of any

other chemical. Given the compound’s

categorization as a ‘‘low risk polymer’’

(40 CFR 723.250) and its proposed use

as an inert ingredient in pesticide

formulations, there is no reasonable

expectation of increased risk due to

cumulative exposure.

D. International Tolerances

Westvaco is petitioning that acrylic

acid, styrene, alpha-methyl styrene

copolymer ammonium salt be exempt

from the requirement of a tolerance

based upon its status as a low risk

polymer as per 40 CFR 723.250.

Therefore, analytical method to

determine residues of acrylic acid,

styrene, alpha-methyl styrene

copolymer in raw agricultural

commodities treated with pesticide

formulations containing acrylic acid,

styrene, alpha-methyl styrene

copolymer have not been proposed.

2. Westvaco Corporation

PP 6E4750

EPA has received a pesticide petition

(PP 6E4750) from Westvaco

Corporation, Chemical Division, 3950

Faber Place Drive, North Charleston, SC

29405, proposing pursuant to section

408(d) of the Federal Food, Drug and

Cosmetic Act, 21 U.S.C. 346a(d), to

amend 40 CFR part 180 to establish an

exemption from the requirement of a

tolerance for residues of styrene, 2-

ethylhexyl acrylate, butyl acrylate

copolymer (CAS Reg. No. 30795-23-4)

when used as an inert ingredient

(encapsulating agent, dispensers, resins,

fibers and beads) in pesticide

formulations applied to growing crops

or raw agricultural commodities after

harvest, under 40 CFR 180.1001(c) and

applied to animals under 40 CFR

180.1001(e). EPA has determined that

the petition contains data or information

regarding the elements set forth in

section 408(d)(2) of the FFDCA;

however, EPA has not fully evaluated

the sufficiency of the submitted data at

this time or whether the data supports

granting of the petition. Additional data

may be needed before EPA rules on the

petition.

A. Toxicity Data

As part of the EPA policy statement

on inert ingredients published in the

Federal Register of April 22, 1987 (52

FR 13305) (FRL–3190-1), the Agency set

forth a list of studies which would

generally be used to evaluate the risks

posed by the presence of an inert

ingredient in a pesticide formulation.

However, where it can be determined

without the data that the inert

ingredient will present minimal or no

risk, the Agency generally does not

require some or all of the listed studies

to rule on the proposed tolerance or

exemption from the requirement of a

tolerance for an inert ingredient.

Westvaco believes that the data and

information described below is adequate

to ascertain the toxicology and

characterize the risk associated with the

use of styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer (CAS Reg. No.

30795-23-4) as an inert ingredient in

pesticide formulations applied to

growing crops and raw agricultural

commodities after harvest.

In the case of certain chemical

substances that are defined as

‘‘polymers’’, the EPA has established a

set of criteria which identify categories

of polymers that present low risk. These

criteria (described in 40 CFR 723.250)

identify polymers that are relatively

unreactive and stable compared to other

chemical substances as well as polymers

that typically are not readily absorbed.

These properties generally limit a

polymer’s ability to cause adverse

effects. In addition, these criteria

exclude polymers about which little is

known. The EPA believes that polymers

meeting the criteria noted below will

present minimal or no risk.

Styrene, 2-ethylhexyl acrylate, butyl

acrylate copolymer (CAS Reg. No.

30795-23-4) conforms to the definition

of polymer given in 40 CFR 723.250(b)

and meets the following criteria that are

used to identify low risk polymers.

1. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer is not a

cationic polymer, nor is it reasonably

anticipated to become a cationic

polymer in a natural aquatic

environment.

2. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer contains as an

integral part of its composition the

atomic elements carbon, chlorine, and

hydrogen.

3. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer does not

contain as an integral part of its

composition, except as impurities, any

elements other than those listed in 40

CFR 723.250 (d)(2)(ii).

4. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer is not

designed, nor is it reasonably

anticipated to substantially degrade,

decompose, or depolymerize.

5. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer is not

manufactured or imported from

monomers and/or other reactants that

are not already included on the Toxic

Substance Control Act (TSCA) Chemical

Substance Inventory or manufactured

under an applicable TSCA section 5

exemption.

6. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer is not a water

absorbing polymer.

7. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer does not

contain any group as reactive functional

groups.

8. The minimum number-average

molecular weight of styrene, 2-

ethylhexyl acrylate, butyl acrylate

copolymer is listed as 4,228 daltons.

Substances with molecular weights

greater than 400 generally are not

absorbed through the intact skin, and

substances with molecular weights

greater than 1,000 generally are not

absorbed through the intact

gastrointestinal (GI) tract. Chemicals not

absorbed through the skin or GI tract

generally are incapable of eliciting a

toxic response.

9. Styrene, 2-ethylhexyl acrylate,

butyl acrylate copolymer has a numberaverage molecular weight of 4,228 and

contains less than 10% oligomeric

material below molecular weight 500

and less than 25% oligomeric material

below 1,000 molecular weight.

B. Aggregate Exposure

Styrene, 2-ethylhexyl acrylate, butyl

acrylate copolymer formulations have

been in commerce since the mid 1960’s.

The copolymer is ubiquitous in our

every day environment and as it is

commonly used in flexographic printing

inks and coatings such as on
27730 Federal Register / Vol. 63, No. 97 /Wednesday, May 20, 1998 / Notices

newspapers, corrugated boxes (e.g. pizza

boxes) and disposable drinking cups.

Although exposure to styrene, 2-

ethylhexyl acrylate, butyl acrylate

copolymer may occur through dietary

(e.g., food wrapping containing

copolymer) and non-occupational (e.g.,

printed articles) sources, the chemical

characteristics of styrene, 2-ethylhexyl

acrylate, butyl acrylate copolymer lead

to the conclusion that there is a

reasonable certainty of no harm from

aggregate exposure to the polymer.

Given the existing widespread and

historic use of styrene, 2-ethylhexyl

acrylate, butyl acrylate copolymer, any

additional exposure resulting from the

approval of the copolymer as an inert

ingredient in pesticide formulations for

use on growing crops or to raw

agricultural commodities after harvest is

not warranted.

In addition, styrene, 2-ethylhexyl

acrylate, butyl acrylate copolymer is

approved by the Food and Drug

Administration (FDA) under 21 CFR for

contact with food as a component in

adhesives (21 CFR 175.105), coatings

(21 CFR 175.300), and paper and

paperboard (21 CFR 176.170).

C. Cumulative Effects

At this time there is no information to

indicate that any toxic effects produced

by styrene, 2-ethylhexyl acrylate, butyl

acrylate copolymer would be

cumulative with those of any other

chemical. Given the compound’s

categorization as a ‘‘low risk polymer’’

(40 CFR 723.250) and its proposed use

as an inert ingredient in pesticide

formulations, there is no reasonable

expectation of increased risk due to

cumulative exposure.

D. International Tolerances

Westvaco is petitioning that styrene,

2-ethylhexyl acrylate, butyl acrylate

copolymer be exempt from the

requirement of a tolerance based upon

its status as a low risk polymer as per

40 CFR 723.250. Therefore, analytical

methods to determine residues of

styrene, 2-ethylhexyl acrylate, butyl

acrylate copolymer in raw agricultural

commodities treated with pesticide

formulations containing styrene, 2-

ethylhexyl acrylate, butyl acrylate

copolymer have not been proposed.

[FR Doc. 98–13446 Filed 5–19–98; 8:45 am]

BILLING CODE 6560–50–F

FEDERAL DEPOSIT INSURANCE

CORPORATION

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Federal Deposit Insurance

Corporation (FDIC).

ACTION: Notice and request for comment.

SUMMARY: The FDIC, as part of its

continuing effort to reduce paperwork

and respondent burden, invites the

general public and other Federal

agencies to take this opportunity to

comment on proposed and/or

continuing information collections, as

required by the Paperwork Reduction

Act of 1995 (44 U.S.C. chapter 35).

Currently, the FDIC is soliciting

comments concerning the following

collections of information titled: (1)

Procedures for Monitoring Bank Secrecy

Act Compliance; (2) Application to

Participate in a Conversion Transaction;

(3) Application for Waiver of

Prohibition on Receipt of Brokered

Deposits by Adequately Capitalized

Insured Depository Institutions,

Registration of Deposit Brokers; (4)

Notice of Branch Closure and (5) Real

Estate Lending Standards.

DATES: Comments must be submitted on

or before July 20, 1998.

ADDRESSES: Interested parties are

invited to submit written comments to

Tamara R. Manly, Management Analyst

(Regulatory Analysis), (202) 898–7453,

Office of the Executive Secretary, Room

4058, Attention: Comments/OES,

Federal Deposit Insurance Corporation,

550 17th Street N.W., Washington, D.C.

20429. All comments should refer to the

OMB control number. Comments may

be hand-delivered to the guard station at

the rear of the 17th Street Building

(located on F Street), on business days

between 7:00 a.m. and 5:00 p.m. [FAX

number (202) 898–3838; Internet

address: comments@fdic.gov].

A copy of the comments may also be

submitted to the OMB desk officer for

the FDIC: Alexander Hunt, Office of

Information and Regulatory Affairs,

Office of Management and Budget, New

Executive Office Building, Room 3208,

Washington, D.C. 20503.

FOR FURTHER INFORMATION CONTACT:

Tamara R. Manly, at the address

identified above.

SUPPLEMENTARY INFORMATION:

Proposal to renew the following

currently approved collections of

information:

1. Title: Procedures for Monitoring

Bank Secrecy Act Compliance.

OMB Number: 3064–0087.

Frequency of Response: On occasion.

Affected Public: Any financial

institution complying with the

requirements of the Bank Secrecy Act.

Estimated Number of Respondents:

8,400.

Estimated Time per Response: .5

hours.

Estimated Total Annual Burden:

4,200 hours.

General Description of Collection: 12

CFR 326 requires all insured nonmenber

banks to establish and maintain

procedures designed to assure and

monitor their compliance with the

requirements of the Bank Secrecy Act

(31 U.S.C. 5311 et seq.) and the

implementing regulations promulgated

thereunder by the Department of

Treasury at 31 CFR 103.

2. Title: Application to Participate in

a Conversion Transaction.

OMB Number: 3064–0098.

Frequency of Response: On occasion.

Affected Public: Any depository

institution participating in a conversion

transaction.

Estimated Number of Respondents:

10.

Estimated Time per Response: 3

hours.

Estimated Total Annual Burden: 30

hours.

General Description of Collection:

Section 5(d) of the Federal Deposit

Insurance Act (12 U.S.C. 1815(d))

provides that no insured depository

institution may participate in a

conversion transaction without the prior

approval of the FDIC and that entrance

and exit fees shall be assessed to the

participating institutions. The FDIC

implements this statutory requirement

by requiring depository institutions

wishing to participate in conversion

transactions to submit a letter

application to obtain FDIC approval.

3. Title: Application for Waiver of

Prohibition on Receipt of Brokered

Deposits by Adequately Capitalized

Insured Depository Institutions,

Registration of Deposit Brokers.

OMB Number: 3064–0099.

Frequency of Response: On occasion.

Affected Public: Any insured

depository institution seeking a waiver

to the prohibition on the acceptance of

brokered deposits.

Estimated Number of Respondents:

175.

Estimated Time per Response: 2.2.

Estimated Total Annual Burden: 385

hours.

General Description of Collection:

Section 29 of the Federal Deposit

Insurance Act prohibits

undercapitalized insured depository

institutions from accepting, renewing,

or rolling over any brokered deposits.